Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 9, 2015 - Issue 3
Submit an article Journal homepage
4,310
Views
11
CrossRef citations to date
0
Altmetric
Editorial

The impact of rare EGFR mutations on the treatment response of patients with non-small cell lung cancer

Niki KarachaliouInstituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain
,
Miguel Angel Molina-VilaPangaea Biotech, Barcelona, Spain
&
Rafael RosellInstituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain;Pangaea Biotech, Barcelona, Spain;Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain;Molecular Oncology Research Foundation (MORe), Barcelona, SpainCorrespondence[email protected]
Pages 241-244 | Published online: 20 May 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dimitrios C. Ziogas, Michalis Liontos, Anastasios Kyriazoglou, Georgios Tsironis, Aristotelis Bamias & Meletios-Athanasios Dimopoulos. (2017) Gefitinib: an “orphan” drug for non-small cell lung cancer. Expert Opinion on Orphan Drugs 5:11, pages 899-906.
Read now
Barbara Legius, Sandra Van Den Broecke, Inge Muylle & Vincent Ninane. (2016) Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer. Lung Cancer: Targets and Therapy 7, pages 149-152.
Read now

Articles from other publishers (9)

Pora Kim, Hanyang Li, Junmei Wang & Zhongming Zhao. (2021) Landscape of drug-resistance mutations in kinase regulatory hotspots. Briefings in Bioinformatics 22:3.
Crossref
Lih Poh Lin, Hwei San Loh & Michelle T. T. Tan. (2020) Impedimetric Genosensor Based on Controllable Pi–Pi Functionalization of Zirconia Decorated Graphene Nanoflakes for the Detection of Epidermal Growth Factor Receptor Exon-19 Mutation. IEEE Sensors Journal 20:18, pages 10424-10432.
Crossref
Chia-I Shen, Hsiang-Ling Ho, Yi-Chen Yeh, Chao-Hua Chiu & Teh-Ying Chou. (2020) Epidermal growth factor receptor mutations in non–small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays. Journal of the Chinese Medical Association 83:4, pages 345-349.
Crossref
Markus Falk, Stefanie Schatz & Lukas C. Heukamp. (2019) Molekularpathologie des Lungenkarzinoms: aktuelle Standards und weitere EntwicklungenMolecular pathology of lung cancer: current standards and further developments. Der Pneumologe 16:6, pages 333-342.
Crossref
Pawel Krawczyk, Dariusz M. Kowalski, Rodryg Ramlau, Ewa Kalinka-Warzocha, Kinga Winiarczyk, Katarzyna Stencel, Tomasz Powrózek, Katarzyna Reszka, Kamila Wojas-Krawczyk, Maciej Bryl, Magdalena Wójcik-Superczyńska, Maciej Głogowski, Aleksander Barinow-Wojewódzki, Janusz Milanowski & Maciej Krzakowski. (2017) Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations. Oncology Letters 13:6, pages 4433-4444.
Crossref
Olivier Calvayrac, Anne Pradines, Elvire Pons, Julien Mazières & Nicolas Guibert. (2017) Molecular biomarkers for lung adenocarcinoma. European Respiratory Journal 49:4, pages 1601734.
Crossref
Jianlin Xu, Bo Jin, Tianqing Chu, Xue Dong, Haitang Yang, Yanwei Zhang, Dan Wu, Yuqing Lou, Xueyan Zhang, Huiming Wang & Baohui Han. (2016) EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China. Lung Cancer 96, pages 87-92.
Crossref
Dickran Kazandjian, Gideon M. Blumenthal, Weishi Yuan, Kun He, Patricia Keegan & Richard Pazdur. (2016) FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation–Positive Non–Small Cell Lung Cancer . Clinical Cancer Research 22:6, pages 1307-1312.
Crossref
J. Raimbourg & J.-Y. Douillard. (2015) Cancers bronchiques non à petites cellules mutés ou réarrangés : de la premiere á la énième ligne. Revue des Maladies Respiratoires Actualités 7:4, pages 497-505.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.